Bovine respiratory disease

Zoetis Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Tuesday, February 14, 2023
Other Health, General Health, Pharmaceutical, Medical Devices, Hospitals, Clinical Trials, Veterinary, COVID-19, Biotechnology, Medical Supplies, FDA, Health, Tick, Sarolaner, Pig, Vaccine, Cat, Veterinarian, FEC, Investment, Animal, Bovine respiratory disease, Pain, NYSE, BRD, Acquisition, PCV2, Livestock, Face, Artificial intelligence, Webcast, Mycoplasma bovis, Dermatology, Growth, International, Inc., Sheep, European, Poultry, Dog, Video game, Medical device, Mycoplasma, Zoetis, Diagnosis, EU

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.
  • The company reported revenue of $2.0 billion for the fourth quarter of 2022, which was an increase of 4% compared with the fourth quarter of 2021.
  • On an operational1 basis, revenue for the fourth quarter of 2022 increased 9% compared with the fourth quarter of 2021, excluding the impact of foreign currency.
  • Adjusted net income2 for the fourth quarter of 2022 increased 27% operationally, excluding the impact from foreign currency.

Worldwide Bovine Respiratory Disease Treatment Industry to 2030: North America Currently Dominates the Market - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023
Infectious Diseases, Health, Veterinary, Farmer, Vaccine, Upper respiratory tract infection, Bovinae, Bovine respiratory disease, Vaccination, Meat, Lower respiratory tract infection, Cattle, Animal husbandry, Growth, Prevalence, Hospital, Infection, Livestock

Geographically, the global bovine respiratory diseases treatment market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Key Points: 
  • Geographically, the global bovine respiratory diseases treatment market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
  • Among the considered regional markets, North America currently dominates the global bovine respiratory disease treatment market, followed by Europe.
  • What are the key micro and macro environmental factors that are impacting the growth of Bovine Respiratory Disease Treatment market?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bovine Respiratory Disease Treatment market worldwide?

Global Bovine Respiratory Disease Treatment Market 2022 to 2030: Players Include Bayer, Boehringer Ingelheim, Bimeda, Ceva and Elanco

Retrieved on: 
Thursday, January 26, 2023
Cattle, Pneumonia, Diphtheria, Bovine respiratory disease, Boehringer Ingelheim, Meat, Infection, Hospital, Vaccine, Growth, Bovinae, Lower respiratory tract infection, Prevalence, Farmer, Upper respiratory tract infection, Bayer, Vaccination, Merck & Co., Animal husbandry, Fine chemical, Livestock, Bimeda

This report presents and analyzes the major trends prevalent in the global bovine respiratory disease treatment market and the market size and forecast.

Key Points: 
  • This report presents and analyzes the major trends prevalent in the global bovine respiratory disease treatment market and the market size and forecast.
  • This report categorizes the global bovine respiratory disease treatment market in terms of treatment type, disease type, distribution channel and geographical distribution.
  • Based on treatment types, the global bovine respiratory disease treatment market is categorized into vaccines, antibiotics, immunomodulators and others.
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bovine Respiratory Disease Treatment market worldwide?

Animal Biotechnology Market Size to grow by USD 3.26 billion | 51% of the market's growth to originate from North America| 17,000+ Technavio Reports

Retrieved on: 
Monday, February 21, 2022
FREE, FMD, Salmonella, Growth, Animal, Prevalence, Awareness, Driver, Bovine respiratory disease, Vaccine, BRD, USD, Biotechnology, African swine fever virus, Foot, Student, Avian influenza, Medicine, Teen Driver Challenge, Degenerative disease, Time, Marketing, Fine chemical

North America held the largest animal biotechnology market share in 2021.

Key Points: 
  • North America held the largest animal biotechnology market share in 2021.
  • Furthermore, countries such as Germany, China, Canada, and UK are expected to emerge as prominent markets for animal biotechnology market during the forecast period.
  • In addition, the increasing prevalence of animal diseases will also influence the market's growth positively during the forecast period.
  • Download free sample for highlights on market Drivers & Challenges affecting the animal biotechnology market.

Maxim Integrated Monitors Bovine Respiratory Disease Via Cow Ear Tags

Retrieved on: 
Thursday, July 23, 2020
Bovine respiratory disease, BRD, Respiratory tract infection, Respiratory disease, Animal virology

Maxim Integrated Products, Inc. (NASDAQ: MXIM), working with researchers at Texas A&M University AgriLife Extension, monitored young calves against the onset of bovine respiratory disease (BRD) in a series of experiments designed to examine the challenges and successes in creating a longitudinal health monitor.

Key Points: 
  • Maxim Integrated Products, Inc. (NASDAQ: MXIM), working with researchers at Texas A&M University AgriLife Extension, monitored young calves against the onset of bovine respiratory disease (BRD) in a series of experiments designed to examine the challenges and successes in creating a longitudinal health monitor.
  • BRD, which results in respiratory infections in cattle, is one of the costliest diseases to the livestock industry.
  • Since BRD is a respiratory disease, it makes sense that SpO2 would drop as respiratory infection compromises oxygen intake.
  • For detailed analysis of the BRD experiments and findings, read the blog post, "Can Wearable Health Technology Pinpoint Disease Onset?"

Global Bovine Respiratory Disease Treatment Markets, 2019-2024: Rising Incidence of BRD, Increasing Consumption of Beef, Changing Environmental Factors - ResearchAndMarkets.com

Retrieved on: 
Friday, December 20, 2019
Agriculture, Health, Natural Resources, Veterinary, Bovine respiratory disease, BRD, Beef, Meat, Beef cattle vaccination in Australia, Draft:Beef Cattle Vaccinations in Australia

The increasing consumption of beef and rising population are major factors that are driving the market studied.

Key Points: 
  • The increasing consumption of beef and rising population are major factors that are driving the market studied.
  • Bovine Respiratory Disease (BRD) has a negative impact on both the dairy and beef industries, due to calf mortality, additional labor costs, and treatment expenses.
  • North America dominates the bovine respiratory disease treatment market, owing to the increasing domestic production, consumption, and export of bovine meat.
  • Thus, the increasing consumption and production of bovine meat and rising cases of BRD are expected to propel the growth of the bovine respiratory disease treatment market in the region, over the forecast period.